TAP began in 1977 as a joint venture between two global pharmaceutical leaders, Abbott and Takeda Pharmaceutical Company Limited. Today, TAP is one of the nation's leading pharmaceutical companies and the marketer of Prevacid® (lansoprazole) and Lupron Depot® (leuprolide acetate for depot suspension), both leaders in their classes.

TAP Pharmaceutical Products Inc. is a creative, diverse, and unique company led by a team dedicated to delivering high-quality pharmaceutical products for patients.